Maesaka K, Hikita H, Tahata Y, Nishioka C, et al. Comparative analysis of lenvatinib use after atezolizumab plus bevacizumab versus lenvatinib as first-line therapy in unresectable hepatocellular carcinoma. J Gastroenterol 2025 Oct 25. doi: 10.1007/s00535-025-02308.
PMID: 41139139